In a clear contrast, another study on human pancreatic cancer cell lines, by employing an unbiased drug screening aiming on the identification of novel tumor cell selective ferroptosis-inducing compounds, identified TRIM25 inducers as a valid therapeutic approach to overcome ferroptosis resistance. This evidence concerns the gene TRIM25 and neoplasm.